These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 24364465)
1. Microtissue density prognostic factor evaluation based on antigens CD34 and CD 105 in ovarian cancer patients. Cwiklnska A; Sobstyl M; Kwasniewski W; Bednarek W Ann Agric Environ Med; 2013; 20(4):838-42. PubMed ID: 24364465 [TBL] [Abstract][Full Text] [Related]
2. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer. Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208 [TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of microvessel density in ovarian cancer]. Rossochacka-Rostalska B; Gisterek IJ; Suder E; Szelachowska JK; Matkowski RA; Lacko A; Kornafel JA Wiad Lek; 2007; 60(3-4):129-37. PubMed ID: 17726864 [TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856 [TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
10. [Expression of selected angiogenesis markers and modulators in pre-, peri- and postmenopausal women with ovarian cancer]. Bednarek W; Mazurek M; Cwiklińska A; Barczyński B Ginekol Pol; 2009 Feb; 80(2):93-8. PubMed ID: 19338204 [TBL] [Abstract][Full Text] [Related]
11. The prognostic value of endoglin (CD105) expression in ovarian carcinoma. Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973 [TBL] [Abstract][Full Text] [Related]
12. Microvessel density assessment in benign and malignant endometrial changes. Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753 [TBL] [Abstract][Full Text] [Related]
13. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast. Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158 [TBL] [Abstract][Full Text] [Related]
14. [Association of microvessel density and blood vessel invasion with the prognosis in rectal carcinoma at stages I to II]. Zhou YJ; Ye Q; Lu HS; Yang YH; Guan GX; Huang CM; Wang C; Zhang J Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Jul; 13(7):516-9. PubMed ID: 20658366 [TBL] [Abstract][Full Text] [Related]
15. CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells. Kays SK; Kaufmann KB; Abel T; Brendel C; Bonig H; Grez M; Buchholz CJ; Kneissl S Stem Cells Dev; 2015 Mar; 24(6):714-23. PubMed ID: 25517513 [TBL] [Abstract][Full Text] [Related]
16. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study. Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712 [TBL] [Abstract][Full Text] [Related]
17. CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients. Martinez LM; Labovsky V; Calcagno ML; Davies KM; Garcia Rivello H; Bianchi MS; Wernicke A; Fernández Vallone VB; Chasseing NA PLoS One; 2015; 10(3):e0121421. PubMed ID: 25803686 [TBL] [Abstract][Full Text] [Related]
18. CD105 expression is an independent predictor of survival in patients with endometrial cancer. Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between CD105 and angiogenesis and biological behaviors in squamous carcinoma of larynx]. Gu X; Xu Y; Wu H; Xu X Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Feb; 20(3):125-8. PubMed ID: 16646406 [TBL] [Abstract][Full Text] [Related]
20. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]